ES8605576A1 - Un procedimiento para preparar una composicion contra infecciones virales de hepatitis b - Google Patents
Un procedimiento para preparar una composicion contra infecciones virales de hepatitis bInfo
- Publication number
- ES8605576A1 ES8605576A1 ES535085A ES535085A ES8605576A1 ES 8605576 A1 ES8605576 A1 ES 8605576A1 ES 535085 A ES535085 A ES 535085A ES 535085 A ES535085 A ES 535085A ES 8605576 A1 ES8605576 A1 ES 8605576A1
- Authority
- ES
- Spain
- Prior art keywords
- vaccines
- against hepatitis
- viral infections
- compositions against
- patient
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 208000036142 Viral infection Diseases 0.000 title abstract 4
- 208000002672 hepatitis B Diseases 0.000 title abstract 4
- 230000009385 viral infection Effects 0.000 title abstract 4
- 239000000203 mixture Substances 0.000 title abstract 3
- 229960005486 vaccine Drugs 0.000 title abstract 3
- 230000015572 biosynthetic process Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2730/00—Reverse transcribing DNA viruses
- C12N2730/00011—Details
- C12N2730/10011—Hepadnaviridae
- C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
- C12N2730/10122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Zoology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Virology (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Gastroenterology & Hepatology (AREA)
- Microbiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicinal Chemistry (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
PROCEDIMIENTO PARA PREPARAR PRODUCTOS QUE PRESENTAN LA ANTIGENICIDAD DE LOS ANTIGENOS VIRALES DE LA HEPATITIS B. COMPRENDE UNA DE LAS SECUENCIAS SIGUIENTES DE OPERACIONES: A) PREPARAR UN EXTRACTO BACTERIANO DE UN ORGANISMO HOSPEDANTE CARACTERIZADO POR LA EXPRESION DE UN POLIPEPTIDO QUE PRESENTA LA ANTIGENICIDAD DEL ANTIGENO DE NUCLEO DEL VIRUS DE LA HEPATITIS B Y TRATAR EL EXTRACTO ENZIMATICA, PROTEOLITICA O DISOCIATIVAMENTE PARA CONVERTIR UNA PARTE DEL POLIPEPTIDO EN UN POLIPEPTIDO QUE PRESENTA LA ANTIGENICIDAD DEL ANTIGENO DEL VIRUS DE LA HEPATITIS B; B) PREPARAR UN EXTRACTO BACTERIANO D EUN ORGANISMO HOSPEDANTE Y RECOGER DEL EXTRACTO UNA FRACCION QUE CONTIENE EL POLIPEPTIDO QUE PRESENTA LA ANTIGENICIDAD DEL ANTIGENO DEL VIRUS DE LA HEPATITIS B; Y C) TRATAR EL EXTACTO ENZIMATICA-PROTEOLITICA O DISOCIATIVAMENTE PARA CONVERTIR UNA PORCION DEL PRECURSOR EN UN POLIPEPTIDO QUE PRESENTA LA ANTIGENICIDAD DEL ANTIGENO E DEL VIRUS DE LA HEPATITIS B Y QUE PRODUCE EN UN PACIENTE TRATADO LA FORMACIONDE ANTICUERPOS PARA LOS ANTIGENOS E DEL VIRUS DE LA HEPATITIS B.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB838321789A GB8321789D0 (en) | 1983-08-12 | 1983-08-12 | Vaccines and compositions against hepatitis |
Publications (2)
Publication Number | Publication Date |
---|---|
ES535085A0 ES535085A0 (es) | 1986-03-16 |
ES8605576A1 true ES8605576A1 (es) | 1986-03-16 |
Family
ID=10547233
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES535085A Expired ES8605576A1 (es) | 1983-08-12 | 1984-08-10 | Un procedimiento para preparar una composicion contra infecciones virales de hepatitis b |
Country Status (12)
Country | Link |
---|---|
EP (1) | EP0133599A3 (es) |
JP (1) | JPS6069030A (es) |
KR (1) | KR850001532A (es) |
AU (1) | AU572178B2 (es) |
CA (1) | CA1259566A (es) |
ES (1) | ES8605576A1 (es) |
FI (1) | FI843163A (es) |
GB (1) | GB8321789D0 (es) |
HU (1) | HUT34890A (es) |
IL (1) | IL72655A0 (es) |
IN (1) | IN158222B (es) |
PT (1) | PT79064B (es) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP7115836B2 (ja) * | 2017-11-07 | 2022-08-09 | エム・ブイ・イー・バイオロジカル・ソリューションズ・ユー・エス・リミテッド・ライアビリティ・カンパニー | 極低温冷凍機 |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3636191A (en) * | 1969-10-08 | 1972-01-18 | Cancer Res Inst | Vaccine against viral hepatitis and process |
FR2303562A1 (fr) * | 1975-03-14 | 1976-10-08 | Community Blood Council Greate | Nouvelle preparation d'antigene utilisable comme vaccin |
US4164565A (en) * | 1975-03-14 | 1979-08-14 | New York Blood Center, Inc. | Vaccine for active immunization containing hepatitis B surface antigen and associated antigen |
US4017360A (en) * | 1975-05-14 | 1977-04-12 | Merck & Co., Inc. | Method for purifying hepatitis B antigen |
ZA792485B (en) * | 1978-06-07 | 1980-06-25 | New York Blood Center Inc | Vaccine for active immunization containing hepatitis b surface and/or e-antigens |
NO794196L (no) * | 1978-12-22 | 1980-06-24 | Biogen Nv | Fremgangsmaate ved fremstilling av et rekombinert dna molekyl |
US4301250A (en) * | 1979-11-02 | 1981-11-17 | Merck & Co., Inc. | Method of producing hepatitis B surface antigen |
AU8746582A (en) * | 1981-09-02 | 1983-03-10 | Biogen N.V. | Hepatitis b virus e type antigen |
-
1983
- 1983-08-12 GB GB838321789A patent/GB8321789D0/en active Pending
-
1984
- 1984-08-09 CA CA000464463A patent/CA1259566A/en not_active Expired
- 1984-08-09 EP EP84305434A patent/EP0133599A3/en not_active Withdrawn
- 1984-08-10 ES ES535085A patent/ES8605576A1/es not_active Expired
- 1984-08-10 AU AU31776/84A patent/AU572178B2/en not_active Ceased
- 1984-08-10 FI FI843163A patent/FI843163A/fi not_active Application Discontinuation
- 1984-08-10 PT PT79064A patent/PT79064B/pt not_active IP Right Cessation
- 1984-08-12 IL IL72655A patent/IL72655A0/xx unknown
- 1984-08-13 IN IN562/CAL/84A patent/IN158222B/en unknown
- 1984-08-13 JP JP59167950A patent/JPS6069030A/ja active Pending
- 1984-08-13 HU HU843074A patent/HUT34890A/hu unknown
- 1984-08-13 KR KR1019840004850A patent/KR850001532A/ko not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
AU572178B2 (en) | 1988-05-05 |
JPS6069030A (ja) | 1985-04-19 |
HUT34890A (en) | 1985-05-28 |
FI843163A0 (fi) | 1984-08-10 |
KR850001532A (ko) | 1985-03-30 |
EP0133599A3 (en) | 1985-06-12 |
IN158222B (es) | 1986-09-27 |
IL72655A0 (en) | 1984-11-30 |
AU3177684A (en) | 1985-02-14 |
GB8321789D0 (en) | 1983-09-14 |
PT79064A (en) | 1984-09-01 |
ES535085A0 (es) | 1986-03-16 |
EP0133599A2 (en) | 1985-02-27 |
FI843163A (fi) | 1985-02-13 |
PT79064B (en) | 1986-12-11 |
CA1259566A (en) | 1989-09-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB8821049D0 (en) | Method & composition for treatment & prevention of viral infections | |
AU3216695A (en) | Lipid analogs for treating viral infections | |
ES2051641A1 (es) | Procedimientos para la preparacion de compuestos derivados de tiourea. | |
EP0608212A4 (en) | PROCESS FOR TREATING VIRAL INFECTIONS. | |
ES8504459A1 (es) | Procedimiento para preparar factor de transferencia especifico a un virus determinado. | |
GB8803365D0 (en) | Antiviral combination | |
IL105169A0 (en) | Compositions for the treatment of infection and disease caused by hepatitis b virus(hbv) | |
ES8605576A1 (es) | Un procedimiento para preparar una composicion contra infecciones virales de hepatitis b | |
ZA87470B (en) | Method and composition for prophylaxis and treatment of viral infections | |
ZA835360B (en) | Use of sugar derivatives for the prophylaxis and treatment of virus infections | |
EP0452360A4 (en) | Methods and compositions for the prophylaxis and treatment of hepatitis b virus infections | |
UA37251C2 (uk) | Лікарський засіб для лікування або профілактики вірусної інфекції гепатиту в і спосіб лікування вірусної інфекції гепатиту в | |
HUT44439A (en) | Process for inhibiting the reproduction of viruses and virus infections | |
IL102815A0 (en) | Pharmaceutical compositions and method for the treatment of infection caused by the human immunodeficiency virus | |
FI930519A (fi) | Peptider foer blokering av infektioner orsakade av hiv-virus samt foerfarande foer deras anvaendnig | |
HU9403783D0 (en) | Use of bradykinin-antagonists for producing pharmaceutical compositions for treating virus diseases | |
EP1143981A4 (en) | TREATMENT AND PREVENTION OF HIV AND OTHER VIRUS INFECTIONS | |
DE68918127D1 (de) | Peptidbehandlung von hartnäckigen Infektionskrankheiten. | |
ZA932271B (en) | Compositions for the treatment of infection and disease caused by hepatitis B virus (HBV) | |
Genton | Medical Management and Prevention of Thromboembolism | |
ZA908933B (en) | Prevention of glycoprotein enveloped virus infectivity by quinolyloxazole-2-ones | |
ZA897105B (en) | Method and composition for the treatment of viral infections | |
IT8048117A0 (it) | Composizione per il trattamento di infezioni virali e procedimento di preparazione | |
ZA907348B (en) | Method of administering soluble t4 for treatment of human immunodeficiency virus infection | |
GB2125700A (en) | Anti-viral treatment method |